Perfluorocarbon suppresses lipopolysaccharide- and α-toxin-induced interleukin-8 release from alveolar epithelial cells

Neonatology

Volumn 91, Issue 2, 2007, Pages 127-133

  Nakata, Setsuko ^a   Yasui, Kozo ^a   Nakamura, Tomohiko ^b   Kubota, Noriko ^b   Baba, Atsushi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGANO CHILDREN'S HOSPITAL   (Japan)

Author keywords

Toxin; Human pulmonary alveolar epithelial cells (A549); Interleukin 8; Lipopolysaccharide; Perfluorocarbon; Ventilator associated pneumonia

Indexed keywords

ALPHA TOXIN; FLUOROCARBON; FLUOROCARBON 84; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; PERFLUOROOCTYL BROMIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; EXPOSURE; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNOREGULATION; IMMUNOSTIMULATION; LUNG ALVEOLUS CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

BLOOD SUBSTITUTES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FLUOROCARBONS; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; PHOSPHOLIPASE C; PULMONARY ALVEOLI; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33847052753     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000097130     Document Type: Article

References (28)

1. Kollef MH: Ventilator-associated pneumonia. A multivariate analysis. JAMA 1993;270:1965-1970.
2. Warren DK, Shukla SJ, Olsen MA, Kollef MH, Hollenbeak CS, Cox MJ, Cohen MM, Fraser VJ: Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003;31:1312-1317.
3. Apisarnthanarak A, Holzmann-Pazgal G, Hamvas A, Olsen MA, Fraser VJ: Ventilator-associated pneumonia in extremely preterm neonates in a neonatal intensive care unit: characteristics, risk factors, and outcomes. Pediatrics 2003;112:1283-1289.
4. Cordero L, Sananes M, Dedhiya P, Ayers LW: Purulence and gram-negative bacilli in tracheal aspirates of mechanically ventilated very low birth weight infants. J Perinatol 2001;21:376-381.
5. Muehlstedt SG, Richardson CJ, West MA, Lyte M, Rodriguez JL: Cytokines and the pathogenesis of nosocomial pneumonia. Surgery 2001;130:602-611.
6. Rodriguez JL, Miller CG, DeForge LE, Kelty L, Shanley CJ, Bartlett RH, Remick DG: Local production of interleukin-8 is associated with nosocomial pneumonia. J Trauma 1992;33:74-82.
7. Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K: Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 1993;365:654-657.
8. Mulligan MS, Jones ML, Bolanowski MA, Baganoff MP, Deppeler CL, Meyers DM, Ryan US, Ward PA: Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J Immunol 1993;150:5585-5595.
9. Laffon M, Pittet JF, Modelska K, Matthay MA, Young DM: Interleukin-8 mediates injury from smoke inhalation to both the lung endothelial and the alveolar epithelial barriers in rabbits. Am J Respir Crit Care Med 1999;160:1443-1449.
10. Bonten MJ, Froon AH, Gaillard CA, Greve JW, de Leeuw PW, Drent M, Stobberingh EE, Buurman WA: The systemic inflammatory response in the development of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997;156:1105-1113.
11. Leach CL, Greenspan JS, Rubenstein SD, Shaffer TH, Wolfson MR, Jackson JC, Delemos R, Fuhrman BP: Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. The Liquivent Study Group. N Engl J Med 1996;335:761-767.
12. Hirschl RB, Pranikoff T, Wise C, Overbeck MC, Gauger P, Schreiner RJ, Dechert R, Bartlett RH: Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome. JAMA 1996;275:383-389.
13. Papo MC, Paczan PR, Fuhrman BP, Steinhorn DM, Hernan LJ, Leach CL, Holm BA, Fisher JE, Kahn BA: Perfluorocarbon-associated gas exchange improves oxygenation, lung mechanics, and survival in a model of adult respiratory distress syndrome. Crit Care Med 1996;24:466-474.
14. Nesti FD, Fuhrman BP, Steinhorn DM, Papo MC, Hernan LJ, Duffy LC, Fisher JE, Leach CL, Paczan PR, Burak BA: Perfluorocarbon-associated gas exchange in gastric aspiration. Crit Care Med 1994;22:1445-1452.
15. Jeng MJ, Kou YR, Sheu CC, Hwang B: Effects of exogenous surfactant supplementation and partial liquid ventilation on acute lung injury induced by wood smoke inhalation in newborn piglets. Crit Care Med 2003;31:1166-1174.
16. Nakamura T, Tamura M: Partial liquid ventilation with low-dose of perflubron and a low stretch ventilation strategy improves oxygenation in a rabbit model of surfactant-depletion. Biol Neonate 2002;82:66-69.
17. Wakabayashi T, Tamura M, Nakamura T: Partial liquid ventilation with low-dose perfluorochemical and high-frequency oscillation improves oxygenation and lung compliance in a rabbit model of surfactant depletion. Biol Neonate 2005;89:177-182.
18. Smith TM, Steinhorn DM, Thusu K, Fuhrman BP, Dandona P: A liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophages. Crit Care Med 1995;23:1533-1539.
19. Varani, J, Hirschl R, Dame M, Johnson K: Perfluorocarbon protects lung epithelial cells from neutrophil-mediated injury in an in vitro model of liquid ventilation therapy. Shock 1996;6:339-344.
20. Baba A, Kim YK, Zhang H, Liu M, Slutsky AS: Perfluorocarbon blocks tumor necrosis factor-α-induced interleukin-8 release from alveolar epithelial cells in vitro. Crit Care Med 2000;28:1113-1118.
21. Gerbeaux P, Ledoray V, Boussuges A, Molenat F, Jean P, Sainty JM: Diagnosis of nosocomial pneumonia in mechanically ventilated patients: repeatability of the bronchoalveolar lavage. Am J Respir Crit Care Med 1998;157:76-80.
22. Franco ML, Waszak P, Banalec G, Levame M, Lafuma C, Harf A, Delacourt C: LPS-induced lung injury in neonatal rats: changes in gelatinase activities and consequences on lung growth. Am J Physiol Lung Cell Mol Physiol 2002;282:L491-L500.
23. McElroy MC, Harty HR, Hosford GE, Boylan GM, Pittet JF, Foster TJ: Alpha-toxin damages the air-blood barrier of the lung in a rat model of Staphylococcus aureus-induced pneumonia. Infect Immun 1999;67:5541-5544.
24. Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G: A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 1976;17:62-70.
25. Koyama S, Sato E, Nomura H, Kubo K, Miura M, Yamashita T, Nagai S, Izumi T: The potential of various lipopolysaccharides to release IL-8 and G-CSF. Am J Physiol Lung Cell Mol Physiol 2000;278:L658-L666.
26. Rose F, Dahlem G, Guthmann B, Grimminger F, Maus U, Hanze J, Duemmer N, Grandel U, Seeger W, Ghofrani HA: Mediator generation and signaling events in alveolar epithelial cells attacked by S. aureus α-toxin. Am J Physiol Lung Cell Mol Physiol 2002;282:L207-L214.
27. Delves PJ, Roitt IM (eds): The Encyclopedia of Immunology, ed 2. Massachusetts, Academic Press, 1998, pp 1466-1471.
28. Land SC, Darakhshan F: Thymulin evokes IL-6-C/EBPbeta regenerative repair and TNF-α silencing during endotoxin exposure in fetal lung explants. Am J Physiol Lung Cell Mol Physiol 2004;286:L473-L487.